今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

苹果智能为iPhone、iPad和Mac引入强大生成式模型：人工智能创作新时代开启

北京，2024年6月14日 - 今天，苹果在WWDC 2024大会上正式发布了备受期待的个人智能化系统“苹果智能”，将强大的生成式模型引入iPhone、iPad和Mac，为用户带来全新的创作体验，并开启人工智能创作新时代。

赋予用户强大创作能力

苹果智能的核心功能是通过强大的生成式模型，帮助用户在文本、图像和代码方面进行创作。用户可以使用简单的指令，例如“写一首关于爱情的诗歌”、“设计一张海报”或“生成一段代码”，即可轻松完成创作任务。

文本创作：灵感触手可及

在文本创作方面，苹果智能能够帮助用户完成各种类型的写作任务，包括诗歌、散文、剧本、邮件、信件等。用户只需输入一些关键词或描述，即可生成相应内容。此外，苹果智能还支持多种语言翻译，方便用户进行跨语言创作。

图像创作：一键生成精美图片

在图像创作方面，苹果智能可以根据用户的描述或草图，生成各种风格的图像，包括照片、插画、绘画等。用户还可以选择不同的图像风格和参数，以获得更加个性化的创作结果。

代码创作：助力开发者高效开发

在代码创作方面，苹果智能可以帮助开发者完成代码生成、代码调试和代码测试等任务，大大提高开发效率。此外，苹果智能还支持多种编程语言，方便开发者进行不同类型的开发工作。

基于Private Cloud Compute的安全性和隐私性

苹果智能采用了基于Private Cloud Compute的架构，确保用户数据的安全性和隐私性。用户的所有创作过程都将运行在用户的设备上，不会上传到云端，因此无需担心数据泄露或隐私侵犯。

**苹果智能的发布，标志着人工智能创作新时代的到来。**凭借强大的生成式模型和对用户隐私的保护，苹果智能将帮助用户释放无限的想象力和创造力，并在各个领域创造出更多精彩的作品。

以下是一些关于苹果智能的额外信息：

• 苹果智能将作为iOS 18、iPadOS 18和macOS Sequoia的一部分，于今年秋季正式发布。
• 苹果智能将支持多种语言，包括中文、英文、法文、德文、西班牙文等。
• 苹果智能将提供免费试用，用户可以使用试用版体验所有功能。

请注意：

• 本新闻稿仅供参考，不构成任何投资建议。
• 本新闻稿中的信息可能存在误差或遗漏，恕不承担任何责任。